SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): March 26, 2003
HAEMONETICS CORPORATION
(Exact Name of Registrant as Specified in its Charter)
Massachusetts 1-10730 04-2882273
------------- ------- ----------
(State or other jurisdiction of (Commission File (IRS Employer
incorporation or organization) Number) Identification
Number)
400 Wood Road
Braintree, MA 02184
------------- -----
(Address of principal executive (Zip Code)
offices)
Registrant's telephone number, including area code (781) 848-7100
Item 5. Other Events and Regulation FD Disclosure
On March 26, 2003, the Company announced that effective April 1, 2003
Brad Nutter will join the Company as President and CEO following the
retirement of James Peterson. Mr. Nutter will replace Mr. Peterson on
Haemonetics' Board of Directors.
Item 7. Financial Statements and Exhibits.
(c) Exhibits.
99.1 Press Release of the Company dated March 26, 2003
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
HAEMONETICS CORPORATION
Date: March 28, 2003 By: /s/Ronald J. Ryan
-------------- --------------------------------
Ronald J. Ryan, Senior Vice President
and Chief Financial Officer
3